Eagle i5 assays detect low-abundance cancer markers in multiple dimensions, directly from blood
EARLY DETECTION OF CANCER
Our Eagle i5 assays detect cancer markers in multiple dimensions, including mutation, methylation, exosomal miRNA, lncRNA and mRNA, translocations and splice variants. From this, we are able to quantitatively determine the cancer marker load in a blood sample. Our cutting-edge, suite of assays allows for single-molecule detection, dramatically improving on existing and well-established approaches. Where necessary, our assays are combined with our Eagle iSeq next-generation sequencing.